Motoki Sekikawa is an expert in Oncology at Shizuoka Cancer Center (Japan). Motoki Sekikawa has authored 39 publications, the most recent in 2026. SLR score: 119 (community average: 125). How the SLR is computed.

LeadR Profile

Motoki Sekikawa Shizuoka Cancer Center Japan
119 ScienceLeadR Reputation 119
Network Map

Oncology

Subspecialties: Pulmonology - Geriatrics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2021 - 2026

Source: PubMed

Shizuoka Cancer Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 39

Citations

Citations: 73 1st author: 4 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study.
PMID 42067397 — cells, lung, pleural effusion, progression-free survival, docetaxel, retrospective studies, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma, edema, pleural effusion, malignant
Thorac Cancer20260
Weight change and impact on prognosis in patients with advanced non-small cell lung cancer with concomitant diabetes mellitus treated with sglt2 inhibitors.
PMID 42049990 — diabetes mellitus, cells, sodium-glucose transporter 2 inhibitors, lung, progression-free survival, neoplasms, carcinoma, non-small-cell lung, drug-related side effects and adverse reactions, lung neoplasms, small cell lung carcinoma, weight loss, therapeutics, palliative care, prognosis, cachexia
Support Care Cancer20260
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
PMID 42033063 — cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma, mutation, egfr mutation
Thorac Cancer20260
Association of FDG-PET/CT findings with adequate tissue samples for gene panel testing in transbronchial lung biopsy and endobronchial ultrasound-guided transbronchial needle aspiration.
PMID 40683173 — regression analysis, cells, research design, genes, lung, tomography, neoplasms, carcinoma, non-small-cell lung, biopsy, positron emission tomography computed tomography, necrosis, tissues, needles
Respir Investig20250
Effect of Cancer Cachexia on the Efficacy and Treatment Delivery of Chemotherapy in Older Patients With Advanced Small Cell Lung Cancer.
PMID 40538154 — cells, lung, neoplasms, drug therapy, lung neoplasms, small cell lung carcinoma, weight loss, drug tapering, therapeutics, etoposide, carboplatin, prognosis, cachexia, chemotherapy, cancer-associated cachexia
Thorac Cancer20250

LeadR Networks

Main global connection map